Dr. Aaron R. Weiss
Claim this profileMaine Children's Cancer Program
Studies Cancer
Studies Rhabdomyosarcoma
9 reported clinical trials
27 drugs studied
Area of expertise
1Cancer
FOXO1 fusion negative
FOXO1 fusion positive
Stage IV
2Rhabdomyosarcoma
FOXO1 fusion negative
FOXO1 fusion positive
Stage IV
Affiliated Hospitals
Clinical Trials Aaron R. Weiss is currently running
Chemotherapy
for Wilms Tumor
This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo (ifosfamide, carboplatin, etoposide, cyclophosphamide, and topotecan) work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT (those treated with only 2 drugs for the initial WT) and regimen ICE/Cyclo/Topo has on patients with high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT).
Recruiting1 award Phase 212 criteria
Chemotherapy
for Rhabdomyosarcoma
This trial uses chemotherapy drugs to treat patients with very low-risk and low-risk rhabdomyosarcoma. The goal is to maintain good outcomes while reducing treatment intensity. The study also examines if patients with specific DNA mutations benefit from more intensive therapy.
Recruiting2 awards Phase 3
More about Aaron R. Weiss
Clinical Trial Related5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Aaron R. Weiss has experience with
- Cyclophosphamide
- Dactinomycin
- Etoposide
- Carboplatin
- Doxorubicin Hydrochloride
- Vincristine
Breakdown of trials Aaron R. Weiss has run
Cancer
Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma
Alveolar Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aaron R. Weiss specialize in?
Aaron R. Weiss focuses on Cancer and Rhabdomyosarcoma. In particular, much of their work with Cancer has involved FOXO1 fusion negative patients, or patients who are FOXO1 fusion positive.
Is Aaron R. Weiss currently recruiting for clinical trials?
Yes, Aaron R. Weiss is currently recruiting for 5 clinical trials in Scarborough Maine. If you're interested in participating, you should apply.
Are there any treatments that Aaron R. Weiss has studied deeply?
Yes, Aaron R. Weiss has studied treatments such as Cyclophosphamide, Dactinomycin, Etoposide.
What is the best way to schedule an appointment with Aaron R. Weiss?
Apply for one of the trials that Aaron R. Weiss is conducting.
What is the office address of Aaron R. Weiss?
The office of Aaron R. Weiss is located at: Maine Children's Cancer Program, Scarborough, Maine 04074 United States. This is the address for their practice at the Maine Children's Cancer Program.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.